Kura Oncology Inc (NASDAQ:KURA)
| 22.07 Delayed Data As of Jun 18 |  -0.38 / -1.69%Today’s Change | 15.88 Today|||52-Week Range 43.00 | -32.42% Year-to-Date |
Latest KURA News | Press Releases
No recent news for Kura Oncology Inc.
Today’s Trading
| Previous close | 22.45 |
| Today’s open | 22.24 |
| Day’s range | 21.29 - 22.24 |
| Volume | 22,527 |
| Average volume (3 months) | 735,517 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 06/18/2021
Growth & Valuation
| Earnings growth (last year) | -12.18% |
| Earnings growth (this year) | -20.12% |
| Earnings growth (next 5 years) | +16.24% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMRXAmneal Pharmaceutica... | -0.36 | -6.47% |
| CYTKCytokinetics Inc | -0.66 | -3.01% |
| ---- | ||
| SUPNSupernus Pharmaceuti... | -0.48 | -1.47% |
Data as of 4:00pm ET, 06/18/2021
Financials
| Next reporting date | August 9, 2021 |
| EPS forecast (this quarter) | -$0.49 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$89.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
